Molbio Diagnostics IPO Details

Molbio Diagnostics Ltd. filed its DRHP with SEBI on August 22, 2025, planning an IPO that includes a fresh issue of Rs. 200 crores and an offer for sale (OFS) of up to 1.26 crore shares.

The shares will be listed on NSE and BSE, with registrar services handled by Kfin Technologies Ltd..

IPO proceeds will primarily fund R&D infrastructure (Rs. 118.08 Cr), new equipment for plants (Rs. 79.04 Cr), and general corporate purposes.

The company, known for its Truenat platform, operates across 80+ countries, offering rapid, portable PCR-based diagnostic solutions endorsed by WHO.

... Read more

Molbio Diagnostics IPO Strengths

  • Innovative Truenat platform – WHO-endorsed rapid molecular test for TB and other infectious diseases.
  • Strong global footprint – Presence in 80+ countries with over 10,000 devices sold.
  • Robust financial growth – PAT up 66% YoY and consistent profitability since FY24.
  • Diversified product portfolio – Devices, diagnostic kits, and radiology solutions through subsidiaries/partners.

Molbio Diagnostics IPO Weaknesses

  • Revenue concentration – Heavy reliance on test kit sales for recurring income.
  • High competition – Faces global diagnostic giants with stronger distribution networks.
  • Dependence on government programs – Large share of revenues tied to public health initiatives.
  • Limited promoter holding post-IPO – May reduce control and influence in strategic decisions.

Molbio Diagnostics Revenue & Profit

Revenue
Profit
Loss
All value in ₹ Billions

3.37

8.41

10.28

10

8

6

4

2

0

2023
2024
2025

Molbio Diagnostics IPO Dates

Open DateTo be announced
Close DateTo be announced
Allotment Date To be announced
Initiation of RefundsTo be announced
Credit of Shares to Demat AccountTo be announced
Listing DateTo be announced

Molbio Diagnostics IPO Lot Size

Minimum Lot SizeTo be announced
Mamximum Lot Size To be announced

Seize the Opportunity! Apply for Molbio Diagnostics IPO

No AMC Charges
Free Demat Account Opening
Low DP Charges
Zero AMC Charges for First Year
Free Expert Research
Low DP Charges (Rs. 10 only)
Free IPO Report & Research

Molbio Diagnostics IPO Subscription Breakup

QIBsTo be announced
Non Institutional InvestorsTo be announced
Retail InvestorsTo be announced

How to Apply for Molbio Diagnostics IPO?

Step 1

First, you need to visit the IPO section on our website.

Step 2

Then, click on the 'IPO Listing' option to view the IPO.

Step 3

Open the Molbio Diagnostics IPO by tapping on it.

Step 4

You will see an option to subscribe that you need to click on.

Step 5

Now that you can see the IPO details, you must enter details like cut-off price, number of lots, and UPI ID.

Step 6

Next, verify your details and select the 'Subscribe' option to complete the bidding.

You have completed your bidding for the Molbio Diagnostics Solutions Limited IPO. Log in and go to the 'IPO Transactions' section to track your allotment status.

Molbio Diagnostics IPO FAQs

Typically, IPO subscriptions close at 5:00 PM IST on the final day, but for UPI-based retail investors, the cut-off time is generally 4:00 PM IST to ensure payment authorization is completed on time. Investors are advised to check the latest schedule and deadlines with their brokers or official sources before applying.

It is possible to check the Molbio Diagnostics Limited IPO allotment status on the portal of your broker or registrar. Information regarding the allotment status is also conveyed via email and SMS from issuing and holding authorities, like the BSE, NSE, CDSL, and NSDL.

Yet to be Announced

Yet to be Announced

Yes, it is possible to revise or cancel an IPO application if you do it within the IPO subscription closing date.

The time of applying for any IPO is usually between Monday and Friday each week, which are the normal business days for the market. Still, it is recommended to contact your registrar for any further information.
Molbio Diagnostics IPO - Listing Date, Price, Lot Size, Analysis & Details